Screener
Monte Rosa Therapeutics, Inc. GLUE Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Monte Rosa Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
FAQ
- What is Monte Rosa Therapeutics, Inc.'s price / sales?
- Monte Rosa Therapeutics, Inc. (GLUE) reported price / sales of 71.2× in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s price / sales changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s price / sales increased by 4244.5% year-over-year, from 1.6× to 71.2×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Monte Rosa Therapeutics, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude